看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
' `$ x/ b# }6 R4 m& h- Q2 m( Q( k
: V6 T6 H0 g+ A) J) j+ m* ~$ _
6 u8 Z" ?. q; P) Q/ M" ~Currently available feasibility data for possible combination strategies.
/ n- g O# Y( t* Z————————————————————————————————. ^' _! {# `5 t Q) Q6 q0 V- G
Combination Feasibility according to preliminary data , n" q- Z2 m6 B6 u' Z
——————————————————————————————————
7 t# x0 E/ a7 I- e$ k0 _' MBevacizumab + sorafenib Yes, reduced dose g" a1 k! w9 g- r0 z
Bevacizumab + sunitinib† No / A0 N) ?+ y! t; a" Q/ ]
Bevacizumab + temsirolimus Yes 0 q1 C5 e/ d8 v$ _
Bevacizumab + everolimus Yes 7 z& x: ^0 J( }5 X
Sorafenib + sunitinib ? $ s; y* S6 [8 C# q
Sorafenib + temsirolimus Yes, reduced dose 2 o+ N6 R5 @# L. e
Sorafenib + everolimus Yes, reduced dose
7 I- b4 n6 b0 K1 ?, DSunitinib + temsirolimus† No 7 I6 p% I+ ~5 W4 F. E" q( u
Sunitinib + everolimus ? W, p& |. |$ [9 a9 n! r
Temsirolimus + everolimus ?
4 v! O- Y3 d$ F% I: M1 o————————————————————! e `5 X1 U' n
†Led to US FDA warning.
5 @# J/ i3 j0 r+ j o/ y8 m3 Y?: As yet unattempted combination.
" d9 d4 h9 s, B3 O |